Municipal Water Monitoring
The Circadian Pulse · 2027 Forecast
Medicare & Medicaid margins won't be saved by primary care.
Rates are tightening, prior-auth denials are rising, and primary-care-centric value-based care has hit its ceiling on total cost of care. The plans that close the specialty-care gap in the next 90 days enter 2027 with a structural cost advantage.
Inpatient & ER Spend decreases most when access to Specialty care is expedited.
The avoidable admissions and ER visits that dominate Medicare & Medicaid cost concentrate in a few chronic conditions — and getting these patients to a specialist faster measurably lowers death, readmission, and downstream utilization.
Across Medicare & Medicaid, plans have squeezed most of what primary-care-centric models can reach. What's left driving avoidable admissions is concentrated in a handful of chronic conditions — heart failure, COPD, uncontrolled diabetes, and the sleep-disordered breathing that compounds them. Rate pressure doesn't shrink that disease burden. It defers the cost. This forecast lays out the three shifts defining the next 90 days, and what the evidence says works.
Three shifts that decide 2027
Rate pressure is tightening, and coding-intensity recalibration compounds it.
After coding-intensity adjustments, plans with chronic-heavy populations are projecting flat-to-negative effective rate movement into the 2027 bid cycle.
Move avoidable specialty utilization off the inpatient ledger with condition-specific virtual specialty care that operates inside the risk arrangement.
Plans with specialty VBC infrastructure enter 2027 with a structural cost advantage rather than a rate problem they can't grow out of.
Cardiology and pulmonology PA denials are rising.
Tighter utilization management delays the specialist visit — it doesn't prevent the admission. For CHF and COPD, a 30-day specialist delay measurably raises readmission probability.
Virtual specialty access within 24–48 hours, working alongside — not against — the plan's UM pathways, so high-risk members are seen before they decompensate.
Speed-to-specialist is a cost-of-care lever, not a member-experience nicety. Getting there first is what avoids the admission.
Primary-care-centric VBC has hit its ceiling on total cost of care.
Across risk-bearing groups, inpatient spend won't move, because the remaining cost drivers are specialty problems that primary care isn't resourced to manage.
Layer integrated cardiology, pulmonology, endocrinology, and sleep management onto the existing VBC model, targeted to the members driving spend.
The next increment of savings comes from specialty care. Groups that add it now define the benchmark others chase.
What the evidence shows
The faster a heart-failure patient reaches a cardiologist after referral, the lower their risk of death and readmission — a large, peer-reviewed cohort shows it directly.
Source: Cinza-Sanjurjo et al., ESC Heart Failure 2025. See references.
In the same cohort, each additional day of delay raised 1-year mortality, and patients seen after more than 14 days carried a 31% higher adjusted mortality risk. Delay doesn't remove demand — it converts a manageable outpatient problem into an inpatient and ER one.
One continuous specialty-care loop
Identification through monitoring, run by specialists, inside the plan's risk arrangement.
- IdentifyRisk-stratify the members driving spend
- EnrollEngage and equip with connected monitoring
- DiagnoseSpecialist assessment within 24–48h
- TreatCondition-specific specialty management
- MonitorEscalate on deterioration, before the admission
Where the cost sits — and what moves it
Problem, intervention, and the measurable result, by specialty.
Heart failure
CHF readmissions dominate inpatient spend. Structured telemonitoring reduces heart-failure hospitalizations vs. usual care (Cochrane, RR 0.71).
Type 2 diabetes
Uncontrolled diabetes drives downstream cost. Telehealth remote monitoring lowers mean HbA1c vs. usual care (BMC Health Serv Res, 2018).
COPD & sleep
COPD exacerbations are preventable and recurring; sleep-disordered breathing is Medicare & Medicaid's most underdiagnosed CHF/COPD comorbidity. Program outcomes available under case study.
Circadian program figures are observed results from defined populations and measurement periods; each is published with its methodology and comparison group in the corresponding case study.
Sources
- Cinza-Sanjurjo S, Cordero A, Mazón-Ramos P, et al. Delay in cardiology consultation after primary care physician referrals in heart failure: clinical implications. ESC Heart Failure. 2025;12(1):573–581. https://doi.org/10.1002/ehf2.15101
- Inglis SC, Clark RA, Dierckx R, Prieto-Merino D, Cleland JGF. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database of Systematic Reviews 2015;(10):CD007228. (Heart-failure hospitalizations RR 0.71; all-cause mortality RR 0.80.)
- Lee PA, Greenfield G, Pappas Y. The impact of telehealth remote patient monitoring on glycemic control in type 2 diabetes. BMC Health Services Research 2018;18:495. (Mean HbA1c reduction ≈0.55%.)
Hello, World!
